Target
Egl nine homolog 1 [182-426]
Ligand
BDBM373550
Substrate
n/a
Meas. Tech.
PHD enzymatic assay
IC50
39.8±n/a nM
Citation
 Rabinowitz, MHRosen, MDTarantino, KTVenkatesan, H 4-Aminoquinazolin compounds as prolyl hydroxylase inhibitors US Patent  US10246442 Publication Date 4/2/2019 
Target
Name:
Egl nine homolog 1 [182-426]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | HIF-1alpha-PHD2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
27392.37
Organism:
Homo sapiens (Human)
Description:
Q9GZT9[182-426]
Residue:
245
Sequence:
NGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF
  
Inhibitor
Name:
BDBM373550
Synonyms:
1-[6-(2,6-Dimethyl-phenoxy)-4-dipropylamino-7-fluoro-quinazolin-2-yl]-1H-pyrazole-4-carboxylic acid; | US10246442, Example 12 | US10975062, Example 12
Type:
Small organic molecule
Emp. Form.:
C26H28FN5O3
Mol. Mass.:
477.5306
SMILES:
CCCN(CCC)c1nc(nc2cc(F)c(Oc3c(C)cccc3C)cc12)-n1cc(cn1)C(O)=O
Structure:
Search PDB for entries with ligand similarity: